​

Tonix Pharmaceuticals (TNXP) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

TNXP Stock Rating

Tonix Pharmaceuticals stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

TNXP Price Target Upside V Benchmarks

TypeNameUpside
StockTonix Pharmaceuticals-
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$34.54$34.54$34.54
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-1---1
May, 25-1---1
Apr, 25-2---2
Mar, 25-2---2
Feb, 25-2---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 03, 2025Alliance Global PartnersBuyBuyhold
Jul 22, 2024Alliance Global PartnersBuyBuyhold
Apr 11, 2024Noble Capital MarketsOutperformOutperformhold
Jun 02, 2022Noble FinancialBuyBuyhold
May 23, 2022Craig-HallumHolddowngrade

Financial Forecast

EPS Forecast

$-300 $-220 $-140 $-60 $20 $100 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-219.09$-176.60----
Avg Forecast$-267.84$-1.14$-0.62$-0.27$38.72$2.41
High Forecast$-254.72$-0.07$-0.04$-0.09$55.01$3.42
Low Forecast$-281.60$-2.19$-1.20$-0.45$19.80$1.23
Surprise %-18.20%15391.23%----

Revenue Forecast

$0 $180M $360M $540M $720M $900M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.77M$10.09M----
Avg Forecast$10.33M$12.80M$13.35M$30.60M$379.69M$657.95M
High Forecast$10.40M$13.79M$18.14M$40.50M$502.57M$870.88M
Low Forecast$10.26M$11.81M$8.55M$19.10M$236.94M$410.59M
Surprise %-24.83%-21.14%----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-116.66M$-130.04M----
Avg Forecast$-142.79M$-604.19K$-329.83K$-143.77K$20.62M$1.28M
High Forecast$-135.63M$-39.77K$-22.54K$-47.92K$29.29M$1.82M
Low Forecast$-149.95M$-1.17M$-637.13K$-239.62K$10.54M$656.08K
Surprise %-18.30%21422.26%----

TNXP Forecast FAQ

Is Tonix Pharmaceuticals stock a buy?

Tonix Pharmaceuticals stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Tonix Pharmaceuticals is a favorable investment for most analysts.

What is Tonix Pharmaceuticals's price target?

Tonix Pharmaceuticals's price target, set by 7 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $34.54.

How does Tonix Pharmaceuticals stock forecast compare to its benchmarks?

Tonix Pharmaceuticals's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Tonix Pharmaceuticals over the past three months?

  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Tonix Pharmaceuticals’s EPS forecast?

Tonix Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.62, marking a -99.65% decrease from the reported $-177 in 2024. Estimates for the following years are $-0.27 in 2026, $38.72 in 2027, and $2.41 in 2028.

What is Tonix Pharmaceuticals’s revenue forecast?

Tonix Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $13.35M, reflecting a 32.26% increase from the reported $10.09M in 2024. The forecast for 2026 is $30.6M, followed by $379.69M for 2027, and $657.95M for 2028.

What is Tonix Pharmaceuticals’s net income forecast?

Tonix Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $-330K, representing a -99.75% decrease from the reported $-130M in 2024. Projections indicate $-144K in 2026, $20.62M in 2027, and $1.28M in 2028.